Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice

Endocrinology

Volumn 140, Issue 7, 1999, Pages 3354-3362

  Tajima, Toshihiro ^a,b   Ma, Xin Ming ^a   Bornstein, Stefan R ^a   Aguilera, Greti ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CORTICOTROPIN; CYTOCHROME P450; DEXAMETHASONE; MESSENGER RNA; PROGESTERONE; STEROID 21 MONOOXYGENASE;

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DRUG MEGADOSE; FEEDBACK SYSTEM; FEMALE; GENE DELETION; HYPERADRENOCORTICISM; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

EID: 0033305726     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.7.6755     Document Type: Article

References (54)

1. Diagnosis and management of congenital adrenal hyperplasia
2. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
3. Congenital adrenal hyperplasia
4. Growth and final height in classic and nonclassic 21-hydroxylase deficiency
5. Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia
6. New approaches to the treatment of congenital adrenal hyperplasia
7. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia
8. Prenatal treatment of congenital adrenal hyperplasia due to 21 hydroxylase deficiency
9. Regulation of pituitary ACTH secretion during chronic stress
10. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
11. Functional implications of brain corticosteroid receptor diversity
12. Roles of type I and type II corticosteroid receptors in regulation of basal activity in the hypothalamic pituitary adrenal axis during the diurnal trough and the peak: Evidence for a non-additive effect of combined receptor occupation
13. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
14. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency
15. Prenatal treatment of congenital adrenal hyperplasia
16. Prenatal treatment of congenital adrenal hyperplasia: A promising experimental therapy of unproven safety
17. Lethal deletion of the complement component C4 and steroid 21-hydroxylase genes in the mouse H-2 class III region caused by meiotic recombination
18. Steroid 21-hydroxylase deficiency in mice
19. Survival of steroid 21-hydroxylase deficient mice without endogenous corticosteroids after neonatal treatment and genetic rescue by transgenesis as model system for treatment of congenital adrenal hyperplasia in humans
20. Stress specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat
21. Differential expression of corticotropin releasing hormone in developing mouse embryos and adult brain
22. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat
23. Participation of αl-adrenergic receptors in the secretion of hypothalamic corticotropin releasing hormone during stress
24. Feedback control of glucocorticoid production is established during fetal development
25. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
26. Prenatal diagnosis of steroid 21-hydroxylase deficiency using the modified polymerase chain reaction to detect splice site mutations in the CYP21 gene
27. Glucocorticoid exposure in utero: New model for adult hypertension
28. Differential response of type I and type II receptors to changes in plasma steroid levels and circadian rhythmicity
29. Glucocorticoid and mineralocorticoid receptors: Biological and clinical relevance
30. Why dexamethasone poorly penetrates the brain
31. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man
32. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells
33. Endotoxin decreases corticotropin releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary
34. Peptide regulation of pituitary and target tissue function and growth in the primate fetus
35. Regulation of the primate fetal adrenal cortex
36. Development of the hypothalamic pituitary adrenal axis in the fetus
37. Developmental and functional biology of the primate fetal adrenal cortex
38. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis
39. Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids
40. Glucocorticoid stimulates expression of corticotropin releasing hormone gene in human placenta
41. Corticotropin releasing hormone production in the placenta and fetal membranes
42. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins
43. Metabolism of synthetic corticosteroids by 11-beta dehydrogenase in man
44. Induction of cultured bovine adrenocortical zona glomerulosa cell 17-hydroxylase activity by ACTH
45. Ultrastructural dynamics of mitochondrial morphology in varying functional forms of human adrenal cortical adenoma
46. Investigations on the turnover of adrenocortical mitochondria. XI. A stereological study of the effects of chronic treatment with ACTH on the size and number of mitochondria from adult human adrenocortical cells cultured in vitro
47. Structure and dynamics of adrenal mitochondria following stimulation with corticotropin releasing hormone
48. Studies on the transition of the cristal membrane from the orthodox to the aggregated configuration. III Loss of coupling ability of adrenal cortex mitochondria in the orthodox configuration
49. Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: Focus on pituitary adenylate cyclase activating polypeptide
50. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation
51. Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats
52. Fetal ethanol exposure alters pituitary adrenal sensitivity to dexamethasone suppression. Psychoneuroendocrinology
53. Prenatal stress induces a phase advance of circadian corticosterone rhythm in adult rats which is prevented by postnatal stress
54. Neonatal endotoxin exposure alters the development of the hypothalamic pituitary adrenal axis: Early illness and later responsivity to stress